Non‑small cell lung cancer (NSCLC) is one of the most common malignancies with a high
morbidity and mortality rate. Long non‑coding RNAs (lncRNAs) have been reported to be …

Non-small-cell lung cancer (NSCLC) remains one of the most frequent types of lung cancer
characterized by its local advancement at diagnosis. Therefore, identification of new …

Long non‑coding RNAs (lncRNAs) represent a surprisingly novel field in mammalian
transcriptome research. With the development of RNA sequencing technology and …

The discovery that protein-coding genes represent less than 2% of all human genome, and
the evidence that more than 90% of it is actively transcribed, changed the classical point of …

Lung cancer is one of the deadliest forms of cancer affecting society today. Non-coding
RNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs …

Lung cancer has been one of the leading causes of cancer-related death worldwide, and
non-small-cell lung cancer (NSCLC) accounts for the majority of lung cancer morbidity, yet …

Lung cancer is the leading cause of cancer deaths worldwide, yet there remains a lack of
specific and sensitive tools for early diagnosis and targeted therapies. High-throughput …

Previously thought of as junk transcripts and pseudogene remnants, long non-coding RNAs
(lncRNAs) have come into their own over the last decade as an essential component of …

Competing endogenous RNAs (ceRNAs) containing microRNA response elements can
competitively interact with microRNA via miRNA response elements, which can combine …

Lung cancer is the leading cause of cancer-related mortality worldwide. Approximately 80%
of lung cancer cases are non–small cell lung carcinoma (NSCLC). However current …